Table 10. Aerogen Solo Aerosol Performance Testing (Continued)
Albuterol Sulphate
(1mg/ml)
Ipratropium
(0.25mg/ml)
Budesonide
(0.5mg/ml)
Fine particle Dose
(<4.7 μm)
(% of fill)
66.33 - 72.07 68.58 - 73.84 59.36 - 64.17
Ultra-fine Particle
Dose (<1.0 μm)
(% of fill)
5.91 - 9.93 1.85 - 4.19 2.36 - 4.51
Table 11 shows the Inhaled Dose (%) for the Aerogen Solo Nebulizer and
Aerogen Ultra with supplemental gas flow, measured on a breathing
simulator.
Table 11. Inhaled Dose (%) for the Aerogen Solo and Aerogen Ultra
Gas Flow
Rate
(LPM)
Breathing
Profile
Patient Interface
Mouthpiece Open Face Mask Valved Face Mask
0
Adult 73.5 – 61.6 N/A 70.7 – 52.3
Pediatric 54.5 – 45.6 N/A 52.9 – 42.5
2
Adult 73.8 – 59.2 44.0 – 37.7 65.4 - 45.3
Pediatric 55.2 – 40.9 34.4 – 29.2 42.4 - 34.7
6 Adult 52.1 – 47.3 41.6 – 34.7 48.4 – 39.5
Results are Inhaled Dose %, expressed as a % of the Nominal Dose placed in the
Aerogen Solo Nebulizer, across a range of supplemental gas flows. The results
provided are the maximum and minimum values for 3 devices tested at each flow rate
with each interface.
Adult Profile: 500ml Vt, 15BPM, 1:1 I:E; Pediatric Profile: 155ml Vt, 25 BPM, 1:2 I:E.
To Next Page
Loading...
